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Nucleotide excision repair in Escherichia coli is a mul-
tistep process in which DNA damage is removed by in-
cision of the DNA on both sides of the damage, followed
by removal of the oligonucleotide containing the lesion.
The two incision reactions take place in a complex of
damaged DNA with UvrB and UvrC. It has been shown
(Lin, J.-J., and Sancar, A. (1992) J. Biol. Chem. 267,
17688–17692) that the catalytic site for incision on the 5*
side of the damage is located in the UvrC protein. Here
we show that the catalytic site for incision on the 3* side
is in this protein as well, because substitution R42A
abolishes 3* incision, whereas formation of the UvrBC-
DNA complex and the 5* incision reaction are unaf-
fected. Arg42 is part of a region that is homologous to the
catalytic domain of the homing endonuclease I-TevI. We
propose that the UvrC protein consists of two functional
parts, with the N-terminal half for the 3* incision reac-
tion and the C-terminal half containing all the determi-
nants for the 5* incision reaction.
Nucleotide excision repair in Escherichia coli is initiated by
the binding of the UvrA2B complex to DNA containing a dam-
age. Following this, UvrB is loaded onto the site of the damage,
and the UvrA protein is released. The resulting UvrB-DNA
preincision complex is bound by UvrC, leading to incision of the
DNA at the fourth or fifth phosphodiester bond on the 39 side of
the damage. This 39 incision is immediately followed by hydrol-
ysis of the eighth phosphodiester bond at the 59 side of the
damage (for reviews see Refs. 1 and 2). Following 59 incision,
often further DNA cleavage is observed 7 nucleotides from the
59 incision site. This additional incision originates from a dam-
age-independent nuclease activity of the UvrBC-DNA complex
(3, 4).
Several observations have shown that the UvrBC-DNA com-
plexes leading to 39 and 59 incision are structurally different: (i)
The 39 incision requires the binding of ATP, whereas the 59
incision can be activated by either ATP or ADP.1 (ii) For 39
incision to occur the UvrC needs to interact with UvrB via the
homologous coiled-coil domains of the two proteins, whereas 59
incision efficiently occurs in the absence of this interaction (5,
6). (iii) UvrC mutants with single amino acid substitutions
have been isolated that are still capable of inducing 39 incision
but that are defective in 59 incision (7). The latter results
implicated the UvrC residues Asp399, Asp438, Asp466, and
His538 as part of the active site for 59 incision (7). The catalytic
site for 39 incision was originally proposed to be located in the
C-terminal domain of UvrB (8). Later it was shown, however,
that the mutant UvrB on which this hypothesis was based
contained a mutation in the UvrC-binding domain but not in
the active site for 39 incision (5).
In this paper we show that substitution R42A in UvrC abol-
ishes 39 incision. This residue is part of a region that is homol-
ogous to the catalytic domain of the homing endonuclease I-
TevI, indicating that the catalytic site for 39 incision during
nucleotide excision repair is located in this homologous region.
EXPERIMENTAL PROCEDURES
Protein Purifications—Purification of the UvrA, UvrB (9), and UvrC
(10) proteins have been described. UvrC(R42A) was expressed from
plasmid pCA161, which was constructed by site-directed mutagenesis
of pBL12 (11) using the oligonucleotide GACCTGAAAAAAGCGCTTTC-
CAGCTATTTC. The UvrC(R42A) protein was overproduced in the
DuvrC strain CS4927(12) and purified by the same procedure as the
wild type UvrC protein. For the purification of UvrC (351–610) plasmid
pCA137 was constructed in which the truncated UvrC protein fused to
a His tag at its C terminus is expressed from the T7 promoter. The
insert of pCA137 was synthesized by polymerase chain reaction with
primers CAGTAACCATATGAGGGCGCGTTATCTGAAA and AGCGT-
AGCGGATCCTCAGTGATGGTGATGGTGATGTTTCAACGACCAGA-
AGAT using pBL12 as template. The polymerase chain reaction product
was restricted with NdeI and BamHI (sites are underlined in the
primers), and the resulting fragment was inserted in pET11a (13). For
overproduction of the truncated protein strain CS5434 was constructed
by transferring the DuvrC::cam mutation from CS4927 (12) into strain
BL21::DE3 (13), by P1 transduction. CS5434 containing pCA137 was
grown in LB until A600 5 0.4 and 0.5 mM isopropyl-1-thio-b-D-galacto-
pyranoside was added. After 2 h of induction the cells were collected.
For the purification of the truncated UvrC protein the method described
for wild type UvrC was adapted. After the phosphocellulose column, the
proteins were loaded on a blue-Sepharose column (Amersham Pharma-
cia Biotech) in 0.1 M KPO4 (pH 7.5), 0.1 M KCl, 25% glycerol. The
truncated UvrC protein was eluted with a 0.1–1.0 M KCl gradient in the
same buffer. Samples containing UvrC were finally loaded on a Ni21
column that was eluted with a 0–0.25 M imidazole gradient in 0.1 M
KPO4 (pH 7.5), 0.5 M KCl, 25% glycerol.
Construction of Damaged DNA Substrates—The DNA sequence of
substrate G1 is shown in Fig. 1. Substrate G2 is substrate G1 with a
single-stranded nick at the 39 incision position. The cholesterol lesion
was synthesized as a phosphoramidite-protected nucleoside building
block as described.2 Using automated oligonucleotide synthesis, this
building block was directly introduced into DNA. For 59 labeling 4 pmol
of the cholesterol-containing oligo was incubated with 10 units of T4
polynucleotide kinase in 70 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 5 mM
dithiothreitol, and 3 pmol of [g-32P]ATP (7000 Ci/mmol, ICN). After
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incubation at 37 °C for 45 min, the reaction was terminated by incuba-
tion at 80 °C for 10 min in the presence of 20 mM EDTA. G1 was
constructed by hybridizing 4 pmol each of the 50-mer top strand and the
50-mer bottom strand in the presence of 50 mM NaCl and 1 mM EDTA.
G2 was constructed by hybridizing the cholesterol-containing 31-mer,
the adjacent 19-mer, and the 50-mer bottom strand. The substrates
were purified from the nonincorporated nucleotides by G50 gel filtra-
tion in 50 mM Tris-HCl (pH 8.0), 50 mM NaCl.
Incision Assay—The DNA substrates (40 fmol) were incubated with
2.5 nM UvrA, 100 nM UvrB, and 50 nM (mutant) UvrC in 20 ml of
Uvr-endo buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 100 mM KCl,
0.1 mg/ml bovine serum albumin, and 1 mM ATP) as described (14). After
the indicated times the reaction was terminated by adding 2 ml of 2
mg/ml glycogen followed by ethanol precipitation. The incision products
were analyzed on a 15% acrylamide gel containing 7 M urea.
Gel Retardation Assay—The DNA substrates (40 fmol) were incu-
bated with 2.5 nM UvrA, 100 nM UvrB, and 20 nM (mutant) UvrC in
Uvr-endo buffer. The mixture was incubated at 37 °C, and the protein-
DNA complexes were analyzed by loading the samples on a 3.5% native
polyacrylamide gel in 0.53 Tris borate/EDTA.
FIG. 1. DNA substrates used in this study. A, structure of the cholesterol lesion attached to the ribose of a nucleoside. B, DNA sequence of
the 50-mer double-stranded DNA fragment with the cholesterol lesion at position 27 (G1) and the same substrate with a single-stranded nick at
the 39 incision position (G2). The position of the cholesterol is indicated with Ch. The asterisks indicate 59 end labeling with 32P. The long arrows
indicate the positions of the 39 and 59 incision sites. The short arrow indicates the cleavage site of the damage-independent UvrBC activity.
FIG. 2. Domains of the UvrC protein. A, schematic representation of UvrC. Indicated are the regions of homology with I-TevI (residues 19–95)
and with ERCC1 (residues 555–610) and the coiled-coil domain for UvrB interaction (residues 201–240). Residues Asp399, Asp438, Asp466, and
His538 are part of the active site for 59 incision (7), and residue Arg42 is part of the active site for 39 incision (this paper). B, alignment of the
N-terminal domain of UvrC with the homologous regions of three homing endonucleases. Pa, Podospora anserina (CAA38774); Amac, Allomyces
macrogynus (S63649); TEV1, I-TevI (P13299). Conserved residues are in bold type. The asterisks indicate the residues that were shown to be part
of the active site in I-TevI (16, 17).
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RESULTS AND DISCUSSION
The N-terminal region of the UvrC protein contains a region
with similarity to the GIY-YIG family of intron-encoded hom-
ing endonucleases (Ref. 15 and Fig. 2). It has been postulated
that this region in the homing nucleases constitutes the cata-
lytic domain, because amino acid substitutions of residues
ArG27 or Glu75 in the I-TevI nuclease result in proteins that
can bind a homing site substrate but no longer cleave this DNA
(16, 17). To determine whether this region of UvrC has a
similar function we mutated the conserved residue Arg42 by
replacing it with Ala. The UvrC(R42A) mutant protein behaved
identically to the wild type protein during the purification
procedure, indicating that the overall physical properties of the
protein are not affected by the mutation.
Incubation of the 39 prenicked substrate G2 with UvrA,
UvrB, and UvrC(R42A) resulted in a 59 incision as efficient as
with the wild type UvrC (Fig. 3A, lanes 5 and 6). In contrast,
the double-stranded substrate G1 was hardly incised with the
mutant UvrC (Fig. 3A, lane 3). The very low amount of incision
observed with UvrC(R42A) appeared to be due to uncoupled 59
incision (not shown). Low amounts of uncoupled 59 incision
have been observed also on a BPDE-modified DNA substrate
(18). Taken together our results demonstrate that UvrC(R42A)
is defective in 39 but not in 59 incision. The additional 59
incision was also efficiently induced by the mutant UvrC. This
damage-independent cleavage by UvrBC has been shown to
use the same catalytic site of UvrC that is used for 59 incision
(3). Gel retardation analysis showed that UvrC(R42A) formed
UvrBC-DNA complexes comparable with the wild type protein
(Fig. 3B, lanes 2 and 3). Taken together, the results strongly
indicate that residue Arg42 of UvrC is part of the catalytic site
for 39 incision, suggesting that the region that is homologous to
the homing nucleases forms the catalytic domain.
In Fig. 2A a schematic representation of the UvrC protein is
FIG. 3. Incision and protein-DNA
complex formation by UvrC(R42A). A,
incision of substrates G1 and G2. The
substrates used are indicated above each
panel. The 59 end-labeled DNA substrates
were incubated with the Uvr proteins as
indicated for 30 min. DNA fragments of
50 and 31 nucleotides correspond to the
labeled top strands of substrates G1 and
G2, respectively. Fragments of 19 nucleo-
tides correspond to incision at the 59 site,
and fragments of 12 nucleotides are the
result of the additional 59 incision by
UvrBC. B, gel retardation assay of sub-
strate G1 incubated with the Uvr proteins
as indicated. The positions of the different
Uvr-DNA complexes are shown.
FIG. 4. Incision by UvrC(351–610). The substrates used are indicated above the panels. The 59 end-labeled DNA substrates were incubated
with UvrAB and UvrCwt or UvrC(351–610) (Chalf) as indicated. A, incision of substrate G1. The incision reaction was incubated for 30 min. B,
incision of substrate G2. The reactions were incubated for the indicated times. DNA fragments of 50 and 31 nucleotides correspond to the labeled
top strands of substrates G1 and G2, respectively. Fragments of 19 nucleotides correspond to incision at the 59 site, and fragments of 12 nucleotides
are the result of the additional 59 incision by UvrBC.
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shown. All identified residues of the catalytic site for the 59
incision reaction are located in the C-terminal half of the pro-
tein. This second half of UvrC also contains the DNA-binding
domain that is homologous to ERCC1 and that has been shown
to be important for 59 incision (10). The proposed catalytic
domain for the 39 incision is in the N-terminal half together
with the coiled-coil domain that interacts with UvrB. This
domain has been shown to be essential for 39 incision. The
positions of the different domains suggest that UvrC might
consist of two functional halfs, one for each incision event. To
test this, we tried to overproduce and purify the two halfs of the
protein separately. Attempts to purify the N-terminal part of
UvrC, either spanning residues 1–243 or residues 1–350 were
unsuccessful, because both truncated proteins formed insoluble
aggregates in the cell (not shown). The C-terminal part, from
residues 351 to 610, however, was successfully purified. As
expected, because both the catalytic site and the UvrB-binding
domain for 39 incision are absent, substrate G1 was not incised
at all by UvrC (351–610) (Fig. 4A, lane 2). Substrate G2,
however, was efficiently incised at the 59 incision position by
the C-terminal half of the UvrC protein (Fig. 4B, lanes 6–8).
The truncated UvrC protein did not induce the additional 59
incision. This is in agreement with the observation that this
damage-independent incision event requires the interaction
between the coiled-coil domains of UvrB and UvrC (3) because
in UvrC (351–610) this interaction domain is lacking (Fig. 2A).
The efficiency of the 59 incision induced by the truncated UvrC
protein was somewhat lower compared with that of wild type
UvrC (Fig. 4B). This might be due to the presence of the His tag
fused to the C-terminal end of the mutant protein. On the other
hand it cannot be excluded that the N-terminal half of UvrC
contributes to the 59 incision reaction, e.g. by stabilizing the
conformation of the C-terminal half of the protein or by stabi-
lizing the UvrBC-DNA complex. The efficient incision by the
UvrC (351–610) mutant (50% in 10 min), however, demon-
strates that all important determinants for 59 incision are
located in the C-terminal half of the protein.
In the past it was shown that a fusion of the maltose-binding
protein (MBP)3 with part of the UvrC gene containing the
C-terminal 314 amino acids (Fig. 2A) is capable of complement-
ing for UV sensitivity in vivo (19). The same protein was shown
to even induce 39 incision in vitro, albeit at only about 1% of
wild type UvrC activity. These observations are contradictory
to the results presented here, because the MBP fusion protein
is not only lacking the catalytic domain for 39 incision, as
identified in this paper, but also the coiled-coil domain for
interaction with UvrB. The only way to explain the results
reported for the MBP fusion protein is that both the in vivo
studies and the protein overexpression for the in vitro studies
were done in an E. coli strain that expresses a partially active
UvrC protein from the chromosome. The E. coli strain used in
the MBP fusion studies contained uvrC279::Tn10, which has a
Tn10 insertion in the 39 half of uvrC. As a result this strain
might produce a truncated UvrC protein that still has all the
domains for 39 incision and that might therefore still incise
damaged DNA at the 39 side. The lack of the C-terminal part
prevents subsequent 59 incision, and hence the strain is defi-
cient for repair. The introduced MBP fusion protein, however,
which like UvrC (351–610) is expected to be fully active in 59
insertion, can complete the repair reaction, and as a result UV
resistance is restored. The observed incision in vitro could then
be explained by a co-purification of the chromosome-encoded
Uvr fragment with the MBP fusion protein.
In the eukaryotic nucleotide excision repair system, the 39
and 59 incisions are made by different proteins (20, 21). In this
paper we show that the two incisions in the E. coli system are
induced by the same protein but that for each incision event
distinct protein domains are used. This suggests that also in
the ancestral bacterial repair system the two incisions were
induced by two different proteins and that most likely during
evolution these two proteins have fused into one.
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